Correlation Between Brainsway and Aequus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brainsway and Aequus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brainsway and Aequus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brainsway and Aequus Pharmaceuticals, you can compare the effects of market volatilities on Brainsway and Aequus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brainsway with a short position of Aequus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brainsway and Aequus Pharmaceuticals.

Diversification Opportunities for Brainsway and Aequus Pharmaceuticals

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Brainsway and Aequus is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Brainsway and Aequus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aequus Pharmaceuticals and Brainsway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brainsway are associated (or correlated) with Aequus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aequus Pharmaceuticals has no effect on the direction of Brainsway i.e., Brainsway and Aequus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Brainsway and Aequus Pharmaceuticals

Given the investment horizon of 90 days Brainsway is expected to generate 0.49 times more return on investment than Aequus Pharmaceuticals. However, Brainsway is 2.03 times less risky than Aequus Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Aequus Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest  1,000.00  in Brainsway on September 1, 2024 and sell it today you would lose (13.00) from holding Brainsway or give up 1.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

Brainsway  vs.  Aequus Pharmaceuticals

 Performance 
       Timeline  
Brainsway 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Brainsway are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Brainsway showed solid returns over the last few months and may actually be approaching a breakup point.
Aequus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aequus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Brainsway and Aequus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brainsway and Aequus Pharmaceuticals

The main advantage of trading using opposite Brainsway and Aequus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brainsway position performs unexpectedly, Aequus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aequus Pharmaceuticals will offset losses from the drop in Aequus Pharmaceuticals' long position.
The idea behind Brainsway and Aequus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk